CME Group Enters Licensing Agreement With Morningstar to Offer Derivatives Products
By Kelly Cloonan
CME Group and Morningstar entered a multi-year licensing agreement, allowing the derivatives marketplace to offer products based on the investment insight provider's equity index benchmarks.
Under the agreement, CME Group will sell trading contracts based on the Morningstar Market Indexes, including ones covering U.S. total market, along with large, mid and small cap stocks, the companies said Wednesday.
The deal comes after Morningstar acquired the Center for Research in Security Prices, or CRSP, a provider of historical stock-market data and indexes, earlier this year. The company said it is currently rebranding CRSP to Morningstar Market Indexes.
CME Group said the move aims to enable its clients to use derivatives based on indexes that underpin more than $3 trillion in linked assets. It is also expected to provide clients with a better framework to navigate market volatility, the company said.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
June 10, 2026 17:47 ET (21:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
10 Best Blue-Chip Stocks to Buy for the Long Term
United States